pISSN 2288-6982
eISSN 2288-7105




Phys. Ther. Korea 2020; 27(2): 111-117

Published online May 20, 2020

© Korean Research Society of Physical Therapy

암 환자에 대한 한국어판 FACIT-호흡곤란 10개 항목 단축형 설문지의 신뢰도와 타당도 분석

구본일1, 오덕원2, 이민지3, 김성경4

1청주대학교 대학원 물리치료학과, 2청주대학교 보건의료과학대학 물리치료학과, 3대전대학교 대전한방병원 물리치료실, 4뉴라이프요양병원 물리치료실

Reliability and Validity of Korean Version of FACIT-dyspnea 10 Item Short Form in Patients With Cancer

Bon-il Ku1, MSc, PT, Duck-won Oh2 , PhD, PT, Min-ji Lee3, MPT, PT, Seong-kyeong Kim4, MSc, PT

1Department of Physical Therapy, The Graduate School, Cheongju University, 2Department of Physical Therapy, College of Health and Medical Science, Cheongju University, Cheongju, 3Department of Physical Therapy, Korean Medicine Hospital of Daejeon University, Daejeon, 4Department of Physical Therapy, New Life Convalescence Hospital, Hwasun, Korea

Correspondence to: Duck-won Oh

Received: January 10, 2020; Revised: March 7, 2020; Accepted: April 17, 2020

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Background: The Functional Assessment of Chronic Illness Therapy (FACIT) for Dyspnea was developed to assess multidimensional dyspnea using two subscales (experience of dyspnea and functional limitation) and a total score.
Objects: This study aimed to assess the reliability and validity of the Korean version of the FACIT-dyspnea 10-item short form questionnaire (FACIT-dyspnea-K).
Methods: Subjects were 163 patients with cancer. Dyspnea-related scales (modified Medical Research Council scale [mMRC], European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 [EORTC QLQ-C30], Hospital Anxiety and Depression [HAD], and WHO Performance Scale) were used to validate the FACIT-dyspnea-K.
Results: Internal consistency was confirmed by Cronbach's alpha values of 0.90 and 0.95 in factors 1 and 2, respectively. Convergence validity was determined by comparing the two factors and total score of the FACIT-dyspnea-K with conceptually related assessment tools measuring the physical and emotional effects of dyspnea, with which correlations ranged from 0.364 to 0.567. Criterion validity was established by significant differences in the FACITdyspnea- K score between groups when the patients were classified by performance status as assessed by the WHO performance scale. Furthermore, the FACIT-dyspnea-K showed notable correlations with other dyspnea scales (mMRC, EORTC QLQ-C30, and HAD) for cancer patients (r = 0.28 to 0.54). The test-retest reliability of the two factors and total score of the FACITdyspnea- K appeared to be excellent (Cronbach's alpha = 0.96 to 0.97).
Conclusion: This study supports FACIT-dyspnea-K as a valid and reliable instrument to assess the dyspnea experience of cancer patients in clinical settings.

Keywords: Assessment, Cancer, Dyspnea, Reliability, Validity